Business Description
Utah Medical Products Inc
NAICS : 325414
SIC : 3843
ISIN : US9174881089
Share Class Description:
UTMD: Ordinary SharesTotal Employee Number:
152Description
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 448.86 | |||||
Equity-to-Asset | 0.98 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 56.18 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.1 | |||||
3-Year EBITDA Growth Rate | -15.5 | |||||
3-Year EPS without NRI Growth Rate | -14 | |||||
3-Year FCF Growth Rate | -7.5 | |||||
3-Year Book Growth Rate | 5.9 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.34 | |||||
9-Day RSI | 47.72 | |||||
14-Day RSI | 50.3 | |||||
3-1 Month Momentum % | 2.94 | |||||
6-1 Month Momentum % | 0.87 | |||||
12-1 Month Momentum % | 10.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 48.62 | |||||
Quick Ratio | 44.27 | |||||
Cash Ratio | 42.28 | |||||
Days Inventory | 201.76 | |||||
Days Sales Outstanding | 37.59 | |||||
Days Payable | 21.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.74 | |||||
Dividend Payout Ratio | 0.36 | |||||
3-Year Dividend Growth Rate | 1.7 | |||||
Forward Dividend Yield % | 1.75 | |||||
5-Year Yield-on-Cost % | 2.15 | |||||
3-Year Average Share Buyback Ratio | 4.2 | |||||
Shareholder Yield % | 2.58 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 57.9 | |||||
Operating Margin % | 29.65 | |||||
Net Margin % | 29.04 | |||||
EBITDA Margin % | 36.46 | |||||
FCF Margin % | 31.7 | |||||
OCF Margin % | 32.81 | |||||
ROE % | 8.78 | |||||
ROA % | 8.54 | |||||
ROIC % | 25.08 | |||||
3-Year ROIIC % | 75.6 | |||||
ROC (Joel Greenblatt) % | 54.01 | |||||
ROCE % | 8.91 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.6 | |||||
PE Ratio without NRI | 20.88 | |||||
Shiller PE Ratio | 15.68 | |||||
Price-to-Owner-Earnings | 21.27 | |||||
PS Ratio | 6.26 | |||||
PB Ratio | 1.85 | |||||
Price-to-Tangible-Book | 2.09 | |||||
Price-to-Free-Cash-Flow | 19.81 | |||||
Price-to-Operating-Cash-Flow | 19.14 | |||||
EV-to-EBIT | 12.92 | |||||
EV-to-EBITDA | 10.51 | |||||
EV-to-Revenue | 3.83 | |||||
EV-to-FCF | 12.09 | |||||
Price-to-GF-Value | 1.22 | |||||
Price-to-Projected-FCF | 0.85 | |||||
Price-to-Median-PS-Value | 0.95 | |||||
Price-to-Graham-Number | 1.39 | |||||
| Price-to-Net-Current-Asset-Value | 2.3 | |||||
| Price-to-Net-Cash | 2.65 | |||||
Earnings Yield (Greenblatt) % | 7.74 | |||||
FCF Yield % | 5.07 | |||||
Forward Rate of Return (Yacktman) % | -4.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:UTMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Utah Medical Products Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 36.108 | ||
| EPS (TTM) ($) | 3.282 | ||
| Beta | 0.6974 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.86 | ||
| Volatility % | 21.19 | ||
| 14-Day RSI | 50.3 | ||
| 14-Day ATR ($) | 2.08075 | ||
| 20-Day SMA ($) | 71.3005 | ||
| 12-1 Month Momentum % | 10.54 | ||
| 52-Week Range ($) | 53.66 - 75.75 | ||
| Shares Outstanding (Mil) | 3.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Utah Medical Products Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Utah Medical Products Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-01-29 | In 155 days | ||
| Third quarter earnings results for 2026 | 2026-10-23 | In 57 days | ||
| USD 0.310000 Cash Dividend | 2026-09-17 | In 21 days | ||
| Second quarter earnings results for 2026 | 2026-07-23 | 69.19 (+0.57%) | ||
| USD 0.310000 Cash Dividend | 2026-06-17 | 67.47 (-3.43%) | ||
| General meeting for 2026 | 2026-05-01 12:00 | 65.42 (+1.32%) | ||
| First quarter earnings results for 2026 | 2026-04-23 | 69.63 (+0.10%) | ||
| Annual report for 2025 | 2026-03-27 | 62.60 (-0.89%) | ||
| USD 0.310000 Cash Dividend | 2026-03-17 | 64.00 (+0.47%) | ||
| Fourth quarter earnings results for 2025 | 2026-01-29 | 60.84 (-3.31%) |
Show
Entries
Utah Medical Products Inc Frequently Asked Questions
What is Utah Medical Products Inc(UTMD)'s stock price today?
The current price of UTMD is $70.84. The 52 week high of UTMD is $75.75 and 52 week low is $53.66.
When is next earnings date of Utah Medical Products Inc(UTMD)?
The next earnings date of Utah Medical Products Inc(UTMD) is 2026-10-23 Est..
Does Utah Medical Products Inc(UTMD) pay dividends? If so, how much?
The Dividend Yield %  of Utah Medical Products Inc(UTMD) is 1.74% (As of Today), Highest Dividend Payout Ratio of Utah Medical Products Inc(UTMD) was 0.47. The lowest was 0.21. And the median was 0.32. The  Forward Dividend Yield % of Utah Medical Products Inc(UTMD) is 1.75%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Utah Medical Products Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers